Third investor launches takeover bid for Stada
Pharmaceutical company Stada Arzneimittel AG received an acquisition offer from an unnamed third entity. The statement published on Friday said the new investor, a private equity firm, is ready to pay €58 per share, translating to nearly €4 billion in total. The legally non-binding conditional expression of interest will be considered alongside other opportunities, according to the management.
The German firm based in Bad Vilbel in Hesse earlier said it opened negotiations with Cinven Partners LLP, which set €56 per share or €3.5 billion for taking it over, and Advent International Corp. The latter's offer wasn't disclosed.